Iman Mouloudi

Building tools for a million co-ops

Building tools for a million co-ops

Centenara Labs is a clinical-stage biotechnology company creating therapies to improve healthy aging. Its experienced drug discovery and development team applies a deep understanding of the biology of aging, alongside technological advances in biopharmaceutical R&D, to progress a new generation of medicines that will help people to age better and live longer.

NLC Health Ventures is dedicated to advancing health and making it accessible to everyone. By using entrepreneurship at scale, our unique NLC approach allows us to find inventions and create and support ventures that have the potential to reach the patient. Led by winning teams, together with a dedicated network and driven by data and learnings.

AENU is an early-stage climate tech VC fund focused on Europe. AENU drives systemic transformation in venture capital towards impact, accessibility and stakeholder-alignment that contribute towards #ImpactCapitalism.

Founded in 1997, Pan-European VC Earlybird backs exceptional early-stage companies, supporting them through their growth and development phases and providing financial resources, strategic support, plus access to an international network and capital markets. Through two separate strategies, Earlybird focuses on tech-enabled businesses across software applications, infrastructure, and deep tech, while Earlybird Health focuses on life science breakthroughs accelerated by data-driven analytics and operations. Earlybird also has a pro-bono impact initiative, Vision Lab. With EUR 2.5 billion under management across fund streams and a history of 9 IPOs and 37 trade sales, Earlybird is among Europe’s most established and active venture capital firms. More information: www.earlybird.com X: https://x.com/EarlybirdVC LinkedIn:www.linkedin.com/company/earlybird-venture-capital Instagram: https://www.instagram.com/earlybirdvc/